Early recurrence in peritoneal metastasis of appendiceal neoplasm: Survival and prognostic factors

• Published in: European journal of surgical oncology Vol. 45; no. 12; pp. 2392 - 2397
• Main Authors: Kyang, Lee S., Alzahrani, Nayef A., Alshahrani, Mohammad S., Rahman, Mohammad K., Liauw, Winston, Morris, David L.
• Format: Journal Article
• Language: English
• Published: England Elsevier Ltd 01.12.2019
• Subjects: Appendiceal neoplasm; Cytoreductive surgery; Early recurrence; Intraperitoneal chemotherapy; Peritoneal metastasis; Prognostic factors; Early recurrence; Peritoneal metastasis; Cytoreductive surgery; Intraperitoneal chemotherapy; Prognostic factors; Appendiceal neoplasm
• ISSN: 0748-7983; 1532-2157
• DOI: 10.1016/j.ejso.2019.06.015

Early recurrence (ER) is defined as development of loco-regional peritoneal disease within 12-month of the initial CRS/PIC. Our aims were to identify overall survival (OS), recurrence-free survival (RFS) and independent prognostic factors associated with ER in PM of appendiceal neoplasm. A prospectively-maintained database for patients with appendiceal neoplasm undergoing cytoreductive surgery (CRS) and perioperative intraperitoneal chemotherapy (PIC) from year 1996–2018 was retrospectively analysed. 208 female and 185 male patients were identified. With a median follow-up of 40-month, 40.2% of the patients developed ER. The median OS for ER was 24 months compared to late (LR) at 64 months. Median OS was not reached in non-recurrence (NR). 5-year survival for ER was less favourable compared to LR and NR (19.3%vs54.6%vs94%). No patients in ER group survived beyond 10-year. Independent negative predictors associated with ER on multivariate analysis were male patient (p = 0.013), blood transfusion of >8 units (p = 0.013), elevated preoperative CEA levels (>5 ng/ml; p = 0.002) and hard intraoperative tumour consistency (p < 0.001). Protective factor was a combination of CC1, hard tumour consistency and use of EPIC (p = 0.039). Independent prognostic factors that predicted recurrence of appendiceal PM were PCI >20 (p = 0.049), non-use of EPIC (p = 0.012), hard tumour consistency (p = 0.004) and use of previous chemotherapy (p = 0.023). ER following CRS and PIC of appendiceal PM is associated with reduced survival outcomes. Our data alludes to the importance of optimising the risk factors in order to delay loco-regional recurrence and improve long-term survival of these patients.